about
Polydeoxyribonucleotide (PDRN) restores blood flow in an experimental model of peripheral artery occlusive disease.MicroRNA signatures predict dysregulated vitamin D receptor and calcium pathways status in limb girdle muscle dystrophies (LGMD) 2A/2B.Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment.Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone.Ischemic stroke due to hypoperfusion in a patient with a previously unrecognized Danon disease.Expression of cytoskeleton proteins in central core disease.The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx miceClinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic lociImmunocytochemistry of muscle cytoskeletal proteins in acid maltase deficiencyPerineurium talin immunoreactivity decreases in diabetic neuropathySkeletal muscle disturbances may precede clinical and laboratory evidence of autoimmune hypothyroidismImmunolocalization and activation of nuclear factor-kappaB in the sciatic nerves of rats with experimental autoimmune neuritisImmunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activitySporadic late-onset nemaline myopathy in a woman with multiple myeloma successfully treated with lenalidomide/dexamethasone
P50
Q33381153-E57C68FC-0BDF-4FC2-8B42-34F6C35176C7Q39456602-372A93EC-B7EB-487E-8D72-1E89E6599F83Q41448556-8A6D20C9-1FFB-4A99-B6FF-5E509B39EA14Q43270173-5C1B8900-A905-4CE5-B0DB-6DFA96C17176Q47886445-6C009FBE-82FC-4C8A-BA32-E6DD3FD6F983Q52216558-20DCD046-8AB1-4480-BEAF-BED4886D430AQ62113682-C594DA74-7402-4C75-BB87-2355A03A92B2Q62113718-C24AB700-D2FA-42A0-80C2-627D35775F91Q72476691-796DDAC1-53D8-4CC7-A750-D295EF2AFEE7Q73170711-A7A735AD-C2E9-42F3-95AF-D2191E16C7FAQ77332136-A5B175C3-C2DD-4CEA-B6A3-B5FB495FA63BQ82729495-F81B5F34-A5EC-4EA7-8EE5-08165A956586Q82997604-EF7C929D-E546-44FF-8180-E0DE3A9E8BB4Q86350974-4AB0DFA0-00BE-4950-ADCE-17B54B926647
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alba Migliorato
@ast
Alba Migliorato
@en
Alba Migliorato
@es
Alba Migliorato
@nl
type
label
Alba Migliorato
@ast
Alba Migliorato
@en
Alba Migliorato
@es
Alba Migliorato
@nl
prefLabel
Alba Migliorato
@ast
Alba Migliorato
@en
Alba Migliorato
@es
Alba Migliorato
@nl
P106
P1153
6602460771
P21
P31
P496
0000-0002-9256-6524